Exact Sciences Corporation - Common Stock (EXAS)

Exact Sciences is a biotechnology company focused on the development and commercialization of innovative cancer screening and diagnostic solutions

With a primary emphasis on early detection, the company aims to improve patient outcomes through advanced molecular tests, including non-invasive tests that help identify colorectal cancer and other cancers at an early stage. Exact Sciences combines sophisticated technology, rigorous scientific research, and a commitment to patient care to provide healthcare providers and patients with critical information that can lead to timely interventions and better health management.